{"V1":"!Sample_geo_accession","V2":"GSM142398","V3":"GSM142399","V4":"GSM142400","V5":"GSM142401","V6":"GSM142402","V7":"GSM142403","V8":"GSM142404","V9":"GSM142405","V10":"GSM142406","V11":"GSM142407","V12":"GSM142408","V13":"GSM142409","V14":"GSM142410","V15":"GSM142411","V16":"GSM142412","V17":"GSM142413","V18":"GSM142414","V19":"GSM142415","V20":"GSM142416","V21":"GSM142417","V22":"GSM142418","V23":"GSM142419","V24":"GSM142420","V25":"GSM142421","V26":"GSM142422","V27":"GSM142423"}
{"V1":"!Sample_status","V2":"Public on Oct 28 2006","V3":"Public on Oct 28 2006","V4":"Public on Oct 28 2006","V5":"Public on Oct 28 2006","V6":"Public on Oct 28 2006","V7":"Public on Oct 28 2006","V8":"Public on Oct 28 2006","V9":"Public on Oct 28 2006","V10":"Public on Oct 28 2006","V11":"Public on Oct 28 2006","V12":"Public on Oct 28 2006","V13":"Public on Oct 28 2006","V14":"Public on Oct 28 2006","V15":"Public on Oct 28 2006","V16":"Public on Oct 28 2006","V17":"Public on Oct 28 2006","V18":"Public on Oct 28 2006","V19":"Public on Oct 28 2006","V20":"Public on Oct 28 2006","V21":"Public on Oct 28 2006","V22":"Public on Oct 28 2006","V23":"Public on Oct 28 2006","V24":"Public on Oct 28 2006","V25":"Public on Oct 28 2006","V26":"Public on Oct 28 2006","V27":"Public on Oct 28 2006"}
{"V1":"!Sample_submission_date","V2":"Oct 25 2006","V3":"Oct 25 2006","V4":"Oct 25 2006","V5":"Oct 25 2006","V6":"Oct 25 2006","V7":"Oct 25 2006","V8":"Oct 25 2006","V9":"Oct 25 2006","V10":"Oct 25 2006","V11":"Oct 25 2006","V12":"Oct 25 2006","V13":"Oct 25 2006","V14":"Oct 25 2006","V15":"Oct 25 2006","V16":"Oct 25 2006","V17":"Oct 25 2006","V18":"Oct 25 2006","V19":"Oct 25 2006","V20":"Oct 25 2006","V21":"Oct 25 2006","V22":"Oct 25 2006","V23":"Oct 25 2006","V24":"Oct 25 2006","V25":"Oct 25 2006","V26":"Oct 25 2006","V27":"Oct 25 2006"}
{"V1":"!Sample_last_update_date","V2":"Mar 18 2009","V3":"Mar 18 2009","V4":"Mar 18 2009","V5":"Mar 18 2009","V6":"Mar 18 2009","V7":"Mar 18 2009","V8":"Mar 18 2009","V9":"Mar 18 2009","V10":"Mar 18 2009","V11":"Mar 18 2009","V12":"Mar 18 2009","V13":"Mar 18 2009","V14":"Mar 18 2009","V15":"Mar 18 2009","V16":"Mar 18 2009","V17":"Mar 18 2009","V18":"Mar 18 2009","V19":"Mar 18 2009","V20":"Mar 18 2009","V21":"Mar 18 2009","V22":"Mar 18 2009","V23":"Mar 18 2009","V24":"Mar 18 2009","V25":"Mar 18 2009","V26":"Mar 18 2009","V27":"Mar 18 2009"}
{"V1":"!Sample_type","V2":"RNA","V3":"RNA","V4":"RNA","V5":"RNA","V6":"RNA","V7":"RNA","V8":"RNA","V9":"RNA","V10":"RNA","V11":"RNA","V12":"RNA","V13":"RNA","V14":"RNA","V15":"RNA","V16":"RNA","V17":"RNA","V18":"RNA","V19":"RNA","V20":"RNA","V21":"RNA","V22":"RNA","V23":"RNA","V24":"RNA","V25":"RNA","V26":"RNA","V27":"RNA"}
{"V1":"!Sample_channel_count","V2":"1","V3":"1","V4":"1","V5":"1","V6":"1","V7":"1","V8":"1","V9":"1","V10":"1","V11":"1","V12":"1","V13":"1","V14":"1","V15":"1","V16":"1","V17":"1","V18":"1","V19":"1","V20":"1","V21":"1","V22":"1","V23":"1","V24":"1","V25":"1","V26":"1","V27":"1"}
{"V1":"!Sample_source_name_ch1","V2":"wildtype resting B-Cells","V3":"wildtype activated B-Cells","V4":"E-mu-BRD2 resting B-Cells","V5":"E-mu-BRD2 resting B-Cells","V6":"marginal E-mu-BRD2 mediated lymphoma","V7":"marginal E-mu-BRD2 mediated lymphoma","V8":"marginal E-mu-BRD2 mediated lymphoma","V9":"aggressive E-mu-BRD2 mediated lymphoma","V10":"aggressive E-mu-BRD2 mediated lymphoma","V11":"marginal E-mu-BRD2 mediated lymphoma","V12":"marginal E-mu-BRD2 mediated lymphoma","V13":"marginal E-mu-BRD2 mediated lymphoma","V14":"transitional E-mu-BRD2 mediated lymphoma","V15":"transitional E-mu-BRD2 mediated lymphoma","V16":"transitional E-mu-BRD2 mediated lymphoma","V17":"transitional E-mu-BRD2 mediated lymphoma","V18":"transitional E-mu-BRD2 mediated lymphoma","V19":"E-mu-BRD2 resting B-Cells","V20":"aggressive E-mu-BRD2 mediated lymphoma","V21":"aggressive E-mu-BRD2 mediated lymphoma","V22":"aggressive E-mu-BRD2 mediated lymphoma","V23":"aggressive E-mu-BRD2 mediated lymphoma","V24":"aggressive E-mu-BRD2 mediated lymphoma","V25":"wildtype resting B-Cells","V26":"wildtype activated B-Cells","V27":"wildtype activated B-Cells"}
{"V1":"!Sample_organism_ch1","V2":"Mus musculus","V3":"Mus musculus","V4":"Mus musculus","V5":"Mus musculus","V6":"Mus musculus","V7":"Mus musculus","V8":"Mus musculus","V9":"Mus musculus","V10":"Mus musculus","V11":"Mus musculus","V12":"Mus musculus","V13":"Mus musculus","V14":"Mus musculus","V15":"Mus musculus","V16":"Mus musculus","V17":"Mus musculus","V18":"Mus musculus","V19":"Mus musculus","V20":"Mus musculus","V21":"Mus musculus","V22":"Mus musculus","V23":"Mus musculus","V24":"Mus musculus","V25":"Mus musculus","V26":"Mus musculus","V27":"Mus musculus"}
{"V1":"!Sample_characteristics_ch1","V2":"genotype: wildtype","V3":"genotype: wildtype","V4":"genotype: E-mu-BRD2","V5":"genotype: E-mu-BRD2","V6":"genotype: E-mu-BRD2","V7":"genotype: E-mu-BRD2","V8":"genotype: E-mu-BRD2","V9":"genotype: E-mu-BRD2","V10":"genotype: E-mu-BRD2","V11":"genotype: E-mu-BRD2","V12":"genotype: E-mu-BRD2","V13":"genotype: E-mu-BRD2","V14":"genotype: E-mu-BRD2","V15":"genotype: E-mu-BRD2","V16":"genotype: E-mu-BRD2","V17":"genotype: E-mu-BRD2","V18":"genotype: E-mu-BRD2","V19":"genotype: E-mu-BRD2","V20":"genotype: E-mu-BRD2","V21":"genotype: E-mu-BRD2","V22":"genotype: E-mu-BRD2","V23":"genotype: E-mu-BRD2","V24":"genotype: E-mu-BRD2","V25":"genotype: wildtype","V26":"genotype: wildtype","V27":"genotype: wildtype"}
{"V1":"!Sample_characteristics_ch1","V2":"cell-type: resting","V3":"cell-type: activated","V4":"cell-type: resting","V5":"cell-type: resting","V6":"cell-type: lymphoma_marginal","V7":"cell-type: lymphoma_marginal","V8":"cell-type: lymphoma_marginal","V9":"cell-type: lymphoma_aggressive","V10":"cell-type: lymphoma_aggressive","V11":"cell-type: lymphoma_marginal","V12":"cell-type: lymphoma_marginal","V13":"cell-type: lymphoma_marginal","V14":"cell-type: lymphoma_transitional","V15":"cell-type: lymphoma_transitional","V16":"cell-type: lymphoma_transitional","V17":"cell-type: lymphoma_transitional","V18":"cell-type: lymphoma_transitional","V19":"cell-type: resting","V20":"cell-type: lymphoma_aggressive","V21":"cell-type: lymphoma_aggressive","V22":"cell-type: lymphoma_aggressive","V23":"cell-type: lymphoma_aggressive","V24":"cell-type: lymphoma_aggressive","V25":"cell-type: resting","V26":"cell-type: activated","V27":"cell-type: activated"}
{"V1":"!Sample_characteristics_ch1","V2":"splenomegaly: none","V3":"splenomegaly: none","V4":"splenomegaly: none","V5":"splenomegaly: none","V6":"splenomegaly: marginal","V7":"splenomegaly: mild","V8":"splenomegaly: mild","V9":"splenomegaly: severe","V10":"splenomegaly: severe","V11":"splenomegaly: mild","V12":"splenomegaly: moderate","V13":"splenomegaly: moderate","V14":"splenomegaly: severe","V15":"splenomegaly: severe","V16":"splenomegaly: mild","V17":"splenomegaly: moderately severe","V18":"splenomegaly: moderately severe","V19":"splenomegaly: none","V20":"splenomegaly: severe","V21":"splenomegaly: severe","V22":"splenomegaly: severe","V23":"splenomegaly: severe","V24":"splenomegaly: severe","V25":"splenomegaly: none","V26":"splenomegaly: none","V27":"splenomegaly: none"}
{"V1":"!Sample_characteristics_ch1","V2":"Ig clonality: polyclonal","V3":"Ig clonality: polyclonal","V4":"Ig clonality: polyclonal","V5":"Ig clonality: polyclonal","V6":"Ig clonality: oligoclonal","V7":"Ig clonality: oligoclonal","V8":"Ig clonality: oligoclonal","V9":"Ig clonality: monoclonal","V10":"Ig clonality: monoclonal","V11":"Ig clonality: oligoclonal","V12":"Ig clonality: oligoclonal","V13":"Ig clonality: oligoclonal","V14":"Ig clonality: oligoclonal","V15":"Ig clonality: oligoclonal","V16":"Ig clonality: oligoclonal","V17":"Ig clonality: oligoclonal","V18":"Ig clonality: oligoclonal","V19":"Ig clonality: polyclonal","V20":"Ig clonality: monoclonal","V21":"Ig clonality: monoclonal","V22":"Ig clonality: monoclonal","V23":"Ig clonality: monoclonal","V24":"Ig clonality: monoclonal","V25":"Ig clonality: polyclonal","V26":"Ig clonality: polyclonal","V27":"Ig clonality: polyclonal"}
{"V1":"!Sample_molecule_ch1","V2":"total RNA","V3":"total RNA","V4":"total RNA","V5":"total RNA","V6":"total RNA","V7":"total RNA","V8":"total RNA","V9":"total RNA","V10":"total RNA","V11":"total RNA","V12":"total RNA","V13":"total RNA","V14":"total RNA","V15":"total RNA","V16":"total RNA","V17":"total RNA","V18":"total RNA","V19":"total RNA","V20":"total RNA","V21":"total RNA","V22":"total RNA","V23":"total RNA","V24":"total RNA","V25":"total RNA","V26":"total RNA","V27":"total RNA"}
{"V1":"!Sample_extract_protocol_ch1","V2":"Total RNA was isolated with the guanidinium thiocyanate method, extracted with acid phenol and precipitated from 2-propanol.","V3":"Total RNA was isolated with the guanidinium thiocyanate method, extracted with acid phenol and precipitated from 2-propanol.","V4":"Total RNA was isolated with the guanidinium thiocyanate method, extracted with acid phenol and precipitated from 2-propanol.","V5":"Total RNA was isolated with the guanidinium thiocyanate method, extracted with acid phenol and precipitated from 2-propanol.","V6":"Total RNA was isolated with the guanidinium thiocyanate method, extracted with acid phenol and precipitated from 2-propanol.","V7":"Total RNA was isolated with the guanidinium thiocyanate method, extracted with acid phenol and precipitated from 2-propanol.","V8":"Total RNA was isolated with the guanidinium thiocyanate method, extracted with acid phenol and precipitated from 2-propanol.","V9":"Total RNA was isolated with the guanidinium thiocyanate method, extracted with acid phenol and precipitated from 2-propanol.","V10":"Total RNA was isolated with the guanidinium thiocyanate method, extracted with acid phenol and precipitated from 2-propanol.","V11":"Total RNA was isolated with the guanidinium thiocyanate method, extracted with acid phenol and precipitated from 2-propanol.","V12":"Total RNA was isolated with the guanidinium thiocyanate method, extracted with acid phenol and precipitated from 2-propanol.","V13":"Total RNA was isolated with the guanidinium thiocyanate method, extracted with acid phenol and precipitated from 2-propanol.","V14":"Total RNA was isolated with the guanidinium thiocyanate method, extracted with acid phenol and precipitated from 2-propanol.","V15":"Total RNA was isolated with the guanidinium thiocyanate method, extracted with acid phenol and precipitated from 2-propanol.","V16":"Total RNA was isolated with the guanidinium thiocyanate method, extracted with acid phenol and precipitated from 2-propanol.","V17":"Total RNA was isolated with the guanidinium thiocyanate method, extracted with acid phenol and precipitated from 2-propanol.","V18":"Total RNA was isolated with the guanidinium thiocyanate method, extracted with acid phenol and precipitated from 2-propanol.","V19":"Total RNA was isolated with the guanidinium thiocyanate method, extracted with acid phenol and precipitated from 2-propanol.","V20":"Total RNA was isolated with the guanidinium thiocyanate method, extracted with acid phenol and precipitated from 2-propanol.","V21":"Total RNA was isolated with the guanidinium thiocyanate method, extracted with acid phenol and precipitated from 2-propanol.","V22":"Total RNA was isolated with the guanidinium thiocyanate method, extracted with acid phenol and precipitated from 2-propanol.","V23":"Total RNA was isolated with the guanidinium thiocyanate method, extracted with acid phenol and precipitated from 2-propanol.","V24":"Total RNA was isolated with the guanidinium thiocyanate method, extracted with acid phenol and precipitated from 2-propanol.","V25":"Total RNA was isolated with the guanidinium thiocyanate method, extracted with acid phenol and precipitated from 2-propanol.","V26":"Total RNA was isolated with the guanidinium thiocyanate method, extracted with acid phenol and precipitated from 2-propanol.","V27":"Total RNA was isolated with the guanidinium thiocyanate method, extracted with acid phenol and precipitated from 2-propanol."}
{"V1":"!Sample_label_ch1","V2":"biotin","V3":"biotin","V4":"biotin","V5":"biotin","V6":"biotin","V7":"biotin","V8":"biotin","V9":"biotin","V10":"biotin","V11":"biotin","V12":"biotin","V13":"biotin","V14":"biotin","V15":"biotin","V16":"biotin","V17":"biotin","V18":"biotin","V19":"biotin","V20":"biotin","V21":"biotin","V22":"biotin","V23":"biotin","V24":"biotin","V25":"biotin","V26":"biotin","V27":"biotin"}
{"V1":"!Sample_label_protocol_ch1","V2":"Using a poly-dT primer incorporating a T7 promoter, double-stranded cDNA was synthesized from 10 micrograms total RNA using a cDNA synthesis kit (SuperScript double-stranded cDNA synthesis kit; Invitrogen, Carlsbad, CA).  Double-stranded cDNA was purified by phenol/chloroform extraction using a Phase-Lock Gel (PLG Heavy Brinkmann Instruments, Westbury, NY) followed by ethanol precipitation.  Biotin-labeled cRNA was generated from the double-stranded cDNA template though in-vitro transcription with T7 polymerase, and a nucleotide mix containing biotinylated CTP and UTP (Enzo RNA Transcript Labeling Kit; Enzo Diagnostics, Farmingdale, NY).  The biotinylated cRNA was purified using RNeasy affinity columns (Qiagen, Valencia, MD).","V3":"Using a poly-dT primer incorporating a T7 promoter, double-stranded cDNA was synthesized from 10 micrograms total RNA using a cDNA synthesis kit (SuperScript double-stranded cDNA synthesis kit; Invitrogen, Carlsbad, CA).  Double-stranded cDNA was purified by phenol/chloroform extraction using a Phase-Lock Gel (PLG Heavy Brinkmann Instruments, Westbury, NY) followed by ethanol precipitation.  Biotin-labeled cRNA was generated from the double-stranded cDNA template though in-vitro transcription with T7 polymerase, and a nucleotide mix containing biotinylated CTP and UTP (Enzo RNA Transcript Labeling Kit; Enzo Diagnostics, Farmingdale, NY).  The biotinylated cRNA was purified using RNeasy affinity columns (Qiagen, Valencia, MD).","V4":"Using a poly-dT primer incorporating a T7 promoter, double-stranded cDNA was synthesized from 10 micrograms total RNA using a cDNA synthesis kit (SuperScript double-stranded cDNA synthesis kit; Invitrogen, Carlsbad, CA).  Double-stranded cDNA was purified by phenol/chloroform extraction using a Phase-Lock Gel (PLG Heavy Brinkmann Instruments, Westbury, NY) followed by ethanol precipitation.  Biotin-labeled cRNA was generated from the double-stranded cDNA template though in-vitro transcription with T7 polymerase, and a nucleotide mix containing biotinylated CTP and UTP (Enzo RNA Transcript Labeling Kit; Enzo Diagnostics, Farmingdale, NY).  The biotinylated cRNA was purified using RNeasy affinity columns (Qiagen, Valencia, MD).","V5":"Using a poly-dT primer incorporating a T7 promoter, double-stranded cDNA was synthesized from 10 micrograms total RNA using a cDNA synthesis kit (SuperScript double-stranded cDNA synthesis kit; Invitrogen, Carlsbad, CA).  Double-stranded cDNA was purified by phenol/chloroform extraction using a Phase-Lock Gel (PLG Heavy Brinkmann Instruments, Westbury, NY) followed by ethanol precipitation.  Biotin-labeled cRNA was generated from the double-stranded cDNA template though in-vitro transcription with T7 polymerase, and a nucleotide mix containing biotinylated CTP and UTP (Enzo RNA Transcript Labeling Kit; Enzo Diagnostics, Farmingdale, NY).  The biotinylated cRNA was purified using RNeasy affinity columns (Qiagen, Valencia, MD).","V6":"Using a poly-dT primer incorporating a T7 promoter, double-stranded cDNA was synthesized from 10 micrograms total RNA using a cDNA synthesis kit (SuperScript double-stranded cDNA synthesis kit; Invitrogen, Carlsbad, CA).  Double-stranded cDNA was purified by phenol/chloroform extraction using a Phase-Lock Gel (PLG Heavy Brinkmann Instruments, Westbury, NY) followed by ethanol precipitation.  Biotin-labeled cRNA was generated from the double-stranded cDNA template though in-vitro transcription with T7 polymerase, and a nucleotide mix containing biotinylated CTP and UTP (Enzo RNA Transcript Labeling Kit; Enzo Diagnostics, Farmingdale, NY).  The biotinylated cRNA was purified using RNeasy affinity columns (Qiagen, Valencia, MD).","V7":"Using a poly-dT primer incorporating a T7 promoter, double-stranded cDNA was synthesized from 10 micrograms total RNA using a cDNA synthesis kit (SuperScript double-stranded cDNA synthesis kit; Invitrogen, Carlsbad, CA).  Double-stranded cDNA was purified by phenol/chloroform extraction using a Phase-Lock Gel (PLG Heavy Brinkmann Instruments, Westbury, NY) followed by ethanol precipitation.  Biotin-labeled cRNA was generated from the double-stranded cDNA template though in-vitro transcription with T7 polymerase, and a nucleotide mix containing biotinylated CTP and UTP (Enzo RNA Transcript Labeling Kit; Enzo Diagnostics, Farmingdale, NY).  The biotinylated cRNA was purified using RNeasy affinity columns (Qiagen, Valencia, MD).","V8":"Using a poly-dT primer incorporating a T7 promoter, double-stranded cDNA was synthesized from 10 micrograms total RNA using a cDNA synthesis kit (SuperScript double-stranded cDNA synthesis kit; Invitrogen, Carlsbad, CA).  Double-stranded cDNA was purified by phenol/chloroform extraction using a Phase-Lock Gel (PLG Heavy Brinkmann Instruments, Westbury, NY) followed by ethanol precipitation.  Biotin-labeled cRNA was generated from the double-stranded cDNA template though in-vitro transcription with T7 polymerase, and a nucleotide mix containing biotinylated CTP and UTP (Enzo RNA Transcript Labeling Kit; Enzo Diagnostics, Farmingdale, NY).  The biotinylated cRNA was purified using RNeasy affinity columns (Qiagen, Valencia, MD).","V9":"Using a poly-dT primer incorporating a T7 promoter, double-stranded cDNA was synthesized from 10 micrograms total RNA using a cDNA synthesis kit (SuperScript double-stranded cDNA synthesis kit; Invitrogen, Carlsbad, CA).  Double-stranded cDNA was purified by phenol/chloroform extraction using a Phase-Lock Gel (PLG Heavy Brinkmann Instruments, Westbury, NY) followed by ethanol precipitation.  Biotin-labeled cRNA was generated from the double-stranded cDNA template though in-vitro transcription with T7 polymerase, and a nucleotide mix containing biotinylated CTP and UTP (Enzo RNA Transcript Labeling Kit; Enzo Diagnostics, Farmingdale, NY).  The biotinylated cRNA was purified using RNeasy affinity columns (Qiagen, Valencia, MD).","V10":"Using a poly-dT primer incorporating a T7 promoter, double-stranded cDNA was synthesized from 10 micrograms total RNA using a cDNA synthesis kit (SuperScript double-stranded cDNA synthesis kit; Invitrogen, Carlsbad, CA).  Double-stranded cDNA was purified by phenol/chloroform extraction using a Phase-Lock Gel (PLG Heavy Brinkmann Instruments, Westbury, NY) followed by ethanol precipitation.  Biotin-labeled cRNA was generated from the double-stranded cDNA template though in-vitro transcription with T7 polymerase, and a nucleotide mix containing biotinylated CTP and UTP (Enzo RNA Transcript Labeling Kit; Enzo Diagnostics, Farmingdale, NY).  The biotinylated cRNA was purified using RNeasy affinity columns (Qiagen, Valencia, MD).","V11":"Using a poly-dT primer incorporating a T7 promoter, double-stranded cDNA was synthesized from 10 micrograms total RNA using a cDNA synthesis kit (SuperScript double-stranded cDNA synthesis kit; Invitrogen, Carlsbad, CA).  Double-stranded cDNA was purified by phenol/chloroform extraction using a Phase-Lock Gel (PLG Heavy Brinkmann Instruments, Westbury, NY) followed by ethanol precipitation.  Biotin-labeled cRNA was generated from the double-stranded cDNA template though in-vitro transcription with T7 polymerase, and a nucleotide mix containing biotinylated CTP and UTP (Enzo RNA Transcript Labeling Kit; Enzo Diagnostics, Farmingdale, NY).  The biotinylated cRNA was purified using RNeasy affinity columns (Qiagen, Valencia, MD).","V12":"Using a poly-dT primer incorporating a T7 promoter, double-stranded cDNA was synthesized from 10 micrograms total RNA using a cDNA synthesis kit (SuperScript double-stranded cDNA synthesis kit; Invitrogen, Carlsbad, CA).  Double-stranded cDNA was purified by phenol/chloroform extraction using a Phase-Lock Gel (PLG Heavy Brinkmann Instruments, Westbury, NY) followed by ethanol precipitation.  Biotin-labeled cRNA was generated from the double-stranded cDNA template though in-vitro transcription with T7 polymerase, and a nucleotide mix containing biotinylated CTP and UTP (Enzo RNA Transcript Labeling Kit; Enzo Diagnostics, Farmingdale, NY).  The biotinylated cRNA was purified using RNeasy affinity columns (Qiagen, Valencia, MD).","V13":"Using a poly-dT primer incorporating a T7 promoter, double-stranded cDNA was synthesized from 10 micrograms total RNA using a cDNA synthesis kit (SuperScript double-stranded cDNA synthesis kit; Invitrogen, Carlsbad, CA).  Double-stranded cDNA was purified by phenol/chloroform extraction using a Phase-Lock Gel (PLG Heavy Brinkmann Instruments, Westbury, NY) followed by ethanol precipitation.  Biotin-labeled cRNA was generated from the double-stranded cDNA template though in-vitro transcription with T7 polymerase, and a nucleotide mix containing biotinylated CTP and UTP (Enzo RNA Transcript Labeling Kit; Enzo Diagnostics, Farmingdale, NY).  The biotinylated cRNA was purified using RNeasy affinity columns (Qiagen, Valencia, MD).","V14":"Using a poly-dT primer incorporating a T7 promoter, double-stranded cDNA was synthesized from 10 micrograms total RNA using a cDNA synthesis kit (SuperScript double-stranded cDNA synthesis kit; Invitrogen, Carlsbad, CA).  Double-stranded cDNA was purified by phenol/chloroform extraction using a Phase-Lock Gel (PLG Heavy Brinkmann Instruments, Westbury, NY) followed by ethanol precipitation.  Biotin-labeled cRNA was generated from the double-stranded cDNA template though in-vitro transcription with T7 polymerase, and a nucleotide mix containing biotinylated CTP and UTP (Enzo RNA Transcript Labeling Kit; Enzo Diagnostics, Farmingdale, NY).  The biotinylated cRNA was purified using RNeasy affinity columns (Qiagen, Valencia, MD).","V15":"Using a poly-dT primer incorporating a T7 promoter, double-stranded cDNA was synthesized from 10 micrograms total RNA using a cDNA synthesis kit (SuperScript double-stranded cDNA synthesis kit; Invitrogen, Carlsbad, CA).  Double-stranded cDNA was purified by phenol/chloroform extraction using a Phase-Lock Gel (PLG Heavy Brinkmann Instruments, Westbury, NY) followed by ethanol precipitation.  Biotin-labeled cRNA was generated from the double-stranded cDNA template though in-vitro transcription with T7 polymerase, and a nucleotide mix containing biotinylated CTP and UTP (Enzo RNA Transcript Labeling Kit; Enzo Diagnostics, Farmingdale, NY).  The biotinylated cRNA was purified using RNeasy affinity columns (Qiagen, Valencia, MD).","V16":"Using a poly-dT primer incorporating a T7 promoter, double-stranded cDNA was synthesized from 10 micrograms total RNA using a cDNA synthesis kit (SuperScript double-stranded cDNA synthesis kit; Invitrogen, Carlsbad, CA).  Double-stranded cDNA was purified by phenol/chloroform extraction using a Phase-Lock Gel (PLG Heavy Brinkmann Instruments, Westbury, NY) followed by ethanol precipitation.  Biotin-labeled cRNA was generated from the double-stranded cDNA template though in-vitro transcription with T7 polymerase, and a nucleotide mix containing biotinylated CTP and UTP (Enzo RNA Transcript Labeling Kit; Enzo Diagnostics, Farmingdale, NY).  The biotinylated cRNA was purified using RNeasy affinity columns (Qiagen, Valencia, MD).","V17":"Using a poly-dT primer incorporating a T7 promoter, double-stranded cDNA was synthesized from 10 micrograms total RNA using a cDNA synthesis kit (SuperScript double-stranded cDNA synthesis kit; Invitrogen, Carlsbad, CA).  Double-stranded cDNA was purified by phenol/chloroform extraction using a Phase-Lock Gel (PLG Heavy Brinkmann Instruments, Westbury, NY) followed by ethanol precipitation.  Biotin-labeled cRNA was generated from the double-stranded cDNA template though in-vitro transcription with T7 polymerase, and a nucleotide mix containing biotinylated CTP and UTP (Enzo RNA Transcript Labeling Kit; Enzo Diagnostics, Farmingdale, NY).  The biotinylated cRNA was purified using RNeasy affinity columns (Qiagen, Valencia, MD).","V18":"Using a poly-dT primer incorporating a T7 promoter, double-stranded cDNA was synthesized from 10 micrograms total RNA using a cDNA synthesis kit (SuperScript double-stranded cDNA synthesis kit; Invitrogen, Carlsbad, CA).  Double-stranded cDNA was purified by phenol/chloroform extraction using a Phase-Lock Gel (PLG Heavy Brinkmann Instruments, Westbury, NY) followed by ethanol precipitation.  Biotin-labeled cRNA was generated from the double-stranded cDNA template though in-vitro transcription with T7 polymerase, and a nucleotide mix containing biotinylated CTP and UTP (Enzo RNA Transcript Labeling Kit; Enzo Diagnostics, Farmingdale, NY).  The biotinylated cRNA was purified using RNeasy affinity columns (Qiagen, Valencia, MD).","V19":"Using a poly-dT primer incorporating a T7 promoter, double-stranded cDNA was synthesized from 10 micrograms total RNA using a cDNA synthesis kit (SuperScript double-stranded cDNA synthesis kit; Invitrogen, Carlsbad, CA).  Double-stranded cDNA was purified by phenol/chloroform extraction using a Phase-Lock Gel (PLG Heavy Brinkmann Instruments, Westbury, NY) followed by ethanol precipitation.  Biotin-labeled cRNA was generated from the double-stranded cDNA template though in-vitro transcription with T7 polymerase, and a nucleotide mix containing biotinylated CTP and UTP (Enzo RNA Transcript Labeling Kit; Enzo Diagnostics, Farmingdale, NY).  The biotinylated cRNA was purified using RNeasy affinity columns (Qiagen, Valencia, MD).","V20":"Using a poly-dT primer incorporating a T7 promoter, double-stranded cDNA was synthesized from 10 micrograms total RNA using a cDNA synthesis kit (SuperScript double-stranded cDNA synthesis kit; Invitrogen, Carlsbad, CA).  Double-stranded cDNA was purified by phenol/chloroform extraction using a Phase-Lock Gel (PLG Heavy Brinkmann Instruments, Westbury, NY) followed by ethanol precipitation.  Biotin-labeled cRNA was generated from the double-stranded cDNA template though in-vitro transcription with T7 polymerase, and a nucleotide mix containing biotinylated CTP and UTP (Enzo RNA Transcript Labeling Kit; Enzo Diagnostics, Farmingdale, NY).  The biotinylated cRNA was purified using RNeasy affinity columns (Qiagen, Valencia, MD).","V21":"Using a poly-dT primer incorporating a T7 promoter, double-stranded cDNA was synthesized from 10 micrograms total RNA using a cDNA synthesis kit (SuperScript double-stranded cDNA synthesis kit; Invitrogen, Carlsbad, CA).  Double-stranded cDNA was purified by phenol/chloroform extraction using a Phase-Lock Gel (PLG Heavy Brinkmann Instruments, Westbury, NY) followed by ethanol precipitation.  Biotin-labeled cRNA was generated from the double-stranded cDNA template though in-vitro transcription with T7 polymerase, and a nucleotide mix containing biotinylated CTP and UTP (Enzo RNA Transcript Labeling Kit; Enzo Diagnostics, Farmingdale, NY).  The biotinylated cRNA was purified using RNeasy affinity columns (Qiagen, Valencia, MD).","V22":"Using a poly-dT primer incorporating a T7 promoter, double-stranded cDNA was synthesized from 10 micrograms total RNA using a cDNA synthesis kit (SuperScript double-stranded cDNA synthesis kit; Invitrogen, Carlsbad, CA).  Double-stranded cDNA was purified by phenol/chloroform extraction using a Phase-Lock Gel (PLG Heavy Brinkmann Instruments, Westbury, NY) followed by ethanol precipitation.  Biotin-labeled cRNA was generated from the double-stranded cDNA template though in-vitro transcription with T7 polymerase, and a nucleotide mix containing biotinylated CTP and UTP (Enzo RNA Transcript Labeling Kit; Enzo Diagnostics, Farmingdale, NY).  The biotinylated cRNA was purified using RNeasy affinity columns (Qiagen, Valencia, MD).","V23":"Using a poly-dT primer incorporating a T7 promoter, double-stranded cDNA was synthesized from 10 micrograms total RNA using a cDNA synthesis kit (SuperScript double-stranded cDNA synthesis kit; Invitrogen, Carlsbad, CA).  Double-stranded cDNA was purified by phenol/chloroform extraction using a Phase-Lock Gel (PLG Heavy Brinkmann Instruments, Westbury, NY) followed by ethanol precipitation.  Biotin-labeled cRNA was generated from the double-stranded cDNA template though in-vitro transcription with T7 polymerase, and a nucleotide mix containing biotinylated CTP and UTP (Enzo RNA Transcript Labeling Kit; Enzo Diagnostics, Farmingdale, NY).  The biotinylated cRNA was purified using RNeasy affinity columns (Qiagen, Valencia, MD).","V24":"Using a poly-dT primer incorporating a T7 promoter, double-stranded cDNA was synthesized from 10 micrograms total RNA using a cDNA synthesis kit (SuperScript double-stranded cDNA synthesis kit; Invitrogen, Carlsbad, CA).  Double-stranded cDNA was purified by phenol/chloroform extraction using a Phase-Lock Gel (PLG Heavy Brinkmann Instruments, Westbury, NY) followed by ethanol precipitation.  Biotin-labeled cRNA was generated from the double-stranded cDNA template though in-vitro transcription with T7 polymerase, and a nucleotide mix containing biotinylated CTP and UTP (Enzo RNA Transcript Labeling Kit; Enzo Diagnostics, Farmingdale, NY).  The biotinylated cRNA was purified using RNeasy affinity columns (Qiagen, Valencia, MD).","V25":"Using a poly-dT primer incorporating a T7 promoter, double-stranded cDNA was synthesized from 10 micrograms total RNA using a cDNA synthesis kit (SuperScript double-stranded cDNA synthesis kit; Invitrogen, Carlsbad, CA).  Double-stranded cDNA was purified by phenol/chloroform extraction using a Phase-Lock Gel (PLG Heavy Brinkmann Instruments, Westbury, NY) followed by ethanol precipitation.  Biotin-labeled cRNA was generated from the double-stranded cDNA template though in-vitro transcription with T7 polymerase, and a nucleotide mix containing biotinylated CTP and UTP (Enzo RNA Transcript Labeling Kit; Enzo Diagnostics, Farmingdale, NY).  The biotinylated cRNA was purified using RNeasy affinity columns (Qiagen, Valencia, MD).","V26":"Using a poly-dT primer incorporating a T7 promoter, double-stranded cDNA was synthesized from 10 micrograms total RNA using a cDNA synthesis kit (SuperScript double-stranded cDNA synthesis kit; Invitrogen, Carlsbad, CA).  Double-stranded cDNA was purified by phenol/chloroform extraction using a Phase-Lock Gel (PLG Heavy Brinkmann Instruments, Westbury, NY) followed by ethanol precipitation.  Biotin-labeled cRNA was generated from the double-stranded cDNA template though in-vitro transcription with T7 polymerase, and a nucleotide mix containing biotinylated CTP and UTP (Enzo RNA Transcript Labeling Kit; Enzo Diagnostics, Farmingdale, NY).  The biotinylated cRNA was purified using RNeasy affinity columns (Qiagen, Valencia, MD).","V27":"Using a poly-dT primer incorporating a T7 promoter, double-stranded cDNA was synthesized from 10 micrograms total RNA using a cDNA synthesis kit (SuperScript double-stranded cDNA synthesis kit; Invitrogen, Carlsbad, CA).  Double-stranded cDNA was purified by phenol/chloroform extraction using a Phase-Lock Gel (PLG Heavy Brinkmann Instruments, Westbury, NY) followed by ethanol precipitation.  Biotin-labeled cRNA was generated from the double-stranded cDNA template though in-vitro transcription with T7 polymerase, and a nucleotide mix containing biotinylated CTP and UTP (Enzo RNA Transcript Labeling Kit; Enzo Diagnostics, Farmingdale, NY).  The biotinylated cRNA was purified using RNeasy affinity columns (Qiagen, Valencia, MD)."}
{"V1":"!Sample_taxid_ch1","V2":"10090","V3":"10090","V4":"10090","V5":"10090","V6":"10090","V7":"10090","V8":"10090","V9":"10090","V10":"10090","V11":"10090","V12":"10090","V13":"10090","V14":"10090","V15":"10090","V16":"10090","V17":"10090","V18":"10090","V19":"10090","V20":"10090","V21":"10090","V22":"10090","V23":"10090","V24":"10090","V25":"10090","V26":"10090","V27":"10090"}
{"V1":"!Sample_hyb_protocol","V2":"For each GeneChip, 20 micrograms of the labeled product was fragmented in 40 mM Tris-acetate, pH 8.1, 100mM KOAc, 30mM MgOAc, for 35 minutes at 94 degrees-Celsius, to an average size of 35 to 200 bases.  15 micrograms of this fragmented, biotinylated cRNA, along with hybridization controls supplied by the manufacturer (Affymetrix), were hybridized to the arrays for 16 hours at 45 degrees-Celsius and 60 rpm.  Arrays were washed and stained according to the standard Antibody Amplification for Eukaryotic Targets protocol (Affymetrix).","V3":"For each GeneChip, 20 micrograms of the labeled product was fragmented in 40 mM Tris-acetate, pH 8.1, 100mM KOAc, 30mM MgOAc, for 35 minutes at 94 degrees-Celsius, to an average size of 35 to 200 bases.  15 micrograms of this fragmented, biotinylated cRNA, along with hybridization controls supplied by the manufacturer (Affymetrix), were hybridized to the arrays for 16 hours at 45 degrees-Celsius and 60 rpm.  Arrays were washed and stained according to the standard Antibody Amplification for Eukaryotic Targets protocol (Affymetrix).","V4":"For each GeneChip, 20 micrograms of the labeled product was fragmented in 40 mM Tris-acetate, pH 8.1, 100mM KOAc, 30mM MgOAc, for 35 minutes at 94 degrees-Celsius, to an average size of 35 to 200 bases.  15 micrograms of this fragmented, biotinylated cRNA, along with hybridization controls supplied by the manufacturer (Affymetrix), were hybridized to the arrays for 16 hours at 45 degrees-Celsius and 60 rpm.  Arrays were washed and stained according to the standard Antibody Amplification for Eukaryotic Targets protocol (Affymetrix).","V5":"For each GeneChip, 20 micrograms of the labeled product was fragmented in 40 mM Tris-acetate, pH 8.1, 100mM KOAc, 30mM MgOAc, for 35 minutes at 94 degrees-Celsius, to an average size of 35 to 200 bases.  15 micrograms of this fragmented, biotinylated cRNA, along with hybridization controls supplied by the manufacturer (Affymetrix), were hybridized to the arrays for 16 hours at 45 degrees-Celsius and 60 rpm.  Arrays were washed and stained according to the standard Antibody Amplification for Eukaryotic Targets protocol (Affymetrix).","V6":"For each GeneChip, 20 micrograms of the labeled product was fragmented in 40 mM Tris-acetate, pH 8.1, 100mM KOAc, 30mM MgOAc, for 35 minutes at 94 degrees-Celsius, to an average size of 35 to 200 bases.  15 micrograms of this fragmented, biotinylated cRNA, along with hybridization controls supplied by the manufacturer (Affymetrix), were hybridized to the arrays for 16 hours at 45 degrees-Celsius and 60 rpm.  Arrays were washed and stained according to the standard Antibody Amplification for Eukaryotic Targets protocol (Affymetrix).","V7":"For each GeneChip, 20 micrograms of the labeled product was fragmented in 40 mM Tris-acetate, pH 8.1, 100mM KOAc, 30mM MgOAc, for 35 minutes at 94 degrees-Celsius, to an average size of 35 to 200 bases.  15 micrograms of this fragmented, biotinylated cRNA, along with hybridization controls supplied by the manufacturer (Affymetrix), were hybridized to the arrays for 16 hours at 45 degrees-Celsius and 60 rpm.  Arrays were washed and stained according to the standard Antibody Amplification for Eukaryotic Targets protocol (Affymetrix).","V8":"For each GeneChip, 20 micrograms of the labeled product was fragmented in 40 mM Tris-acetate, pH 8.1, 100mM KOAc, 30mM MgOAc, for 35 minutes at 94 degrees-Celsius, to an average size of 35 to 200 bases.  15 micrograms of this fragmented, biotinylated cRNA, along with hybridization controls supplied by the manufacturer (Affymetrix), were hybridized to the arrays for 16 hours at 45 degrees-Celsius and 60 rpm.  Arrays were washed and stained according to the standard Antibody Amplification for Eukaryotic Targets protocol (Affymetrix).","V9":"For each GeneChip, 20 micrograms of the labeled product was fragmented in 40 mM Tris-acetate, pH 8.1, 100mM KOAc, 30mM MgOAc, for 35 minutes at 94 degrees-Celsius, to an average size of 35 to 200 bases.  15 micrograms of this fragmented, biotinylated cRNA, along with hybridization controls supplied by the manufacturer (Affymetrix), were hybridized to the arrays for 16 hours at 45 degrees-Celsius and 60 rpm.  Arrays were washed and stained according to the standard Antibody Amplification for Eukaryotic Targets protocol (Affymetrix).","V10":"For each GeneChip, 20 micrograms of the labeled product was fragmented in 40 mM Tris-acetate, pH 8.1, 100mM KOAc, 30mM MgOAc, for 35 minutes at 94 degrees-Celsius, to an average size of 35 to 200 bases.  15 micrograms of this fragmented, biotinylated cRNA, along with hybridization controls supplied by the manufacturer (Affymetrix), were hybridized to the arrays for 16 hours at 45 degrees-Celsius and 60 rpm.  Arrays were washed and stained according to the standard Antibody Amplification for Eukaryotic Targets protocol (Affymetrix).","V11":"For each GeneChip, 20 micrograms of the labeled product was fragmented in 40 mM Tris-acetate, pH 8.1, 100mM KOAc, 30mM MgOAc, for 35 minutes at 94 degrees-Celsius, to an average size of 35 to 200 bases.  15 micrograms of this fragmented, biotinylated cRNA, along with hybridization controls supplied by the manufacturer (Affymetrix), were hybridized to the arrays for 16 hours at 45 degrees-Celsius and 60 rpm.  Arrays were washed and stained according to the standard Antibody Amplification for Eukaryotic Targets protocol (Affymetrix).","V12":"For each GeneChip, 20 micrograms of the labeled product was fragmented in 40 mM Tris-acetate, pH 8.1, 100mM KOAc, 30mM MgOAc, for 35 minutes at 94 degrees-Celsius, to an average size of 35 to 200 bases.  15 micrograms of this fragmented, biotinylated cRNA, along with hybridization controls supplied by the manufacturer (Affymetrix), were hybridized to the arrays for 16 hours at 45 degrees-Celsius and 60 rpm.  Arrays were washed and stained according to the standard Antibody Amplification for Eukaryotic Targets protocol (Affymetrix).","V13":"For each GeneChip, 20 micrograms of the labeled product was fragmented in 40 mM Tris-acetate, pH 8.1, 100mM KOAc, 30mM MgOAc, for 35 minutes at 94 degrees-Celsius, to an average size of 35 to 200 bases.  15 micrograms of this fragmented, biotinylated cRNA, along with hybridization controls supplied by the manufacturer (Affymetrix), were hybridized to the arrays for 16 hours at 45 degrees-Celsius and 60 rpm.  Arrays were washed and stained according to the standard Antibody Amplification for Eukaryotic Targets protocol (Affymetrix).","V14":"For each GeneChip, 20 micrograms of the labeled product was fragmented in 40 mM Tris-acetate, pH 8.1, 100mM KOAc, 30mM MgOAc, for 35 minutes at 94 degrees-Celsius, to an average size of 35 to 200 bases.  15 micrograms of this fragmented, biotinylated cRNA, along with hybridization controls supplied by the manufacturer (Affymetrix), were hybridized to the arrays for 16 hours at 45 degrees-Celsius and 60 rpm.  Arrays were washed and stained according to the standard Antibody Amplification for Eukaryotic Targets protocol (Affymetrix).","V15":"For each GeneChip, 20 micrograms of the labeled product was fragmented in 40 mM Tris-acetate, pH 8.1, 100mM KOAc, 30mM MgOAc, for 35 minutes at 94 degrees-Celsius, to an average size of 35 to 200 bases.  15 micrograms of this fragmented, biotinylated cRNA, along with hybridization controls supplied by the manufacturer (Affymetrix), were hybridized to the arrays for 16 hours at 45 degrees-Celsius and 60 rpm.  Arrays were washed and stained according to the standard Antibody Amplification for Eukaryotic Targets protocol (Affymetrix).","V16":"For each GeneChip, 20 micrograms of the labeled product was fragmented in 40 mM Tris-acetate, pH 8.1, 100mM KOAc, 30mM MgOAc, for 35 minutes at 94 degrees-Celsius, to an average size of 35 to 200 bases.  15 micrograms of this fragmented, biotinylated cRNA, along with hybridization controls supplied by the manufacturer (Affymetrix), were hybridized to the arrays for 16 hours at 45 degrees-Celsius and 60 rpm.  Arrays were washed and stained according to the standard Antibody Amplification for Eukaryotic Targets protocol (Affymetrix).","V17":"For each GeneChip, 20 micrograms of the labeled product was fragmented in 40 mM Tris-acetate, pH 8.1, 100mM KOAc, 30mM MgOAc, for 35 minutes at 94 degrees-Celsius, to an average size of 35 to 200 bases.  15 micrograms of this fragmented, biotinylated cRNA, along with hybridization controls supplied by the manufacturer (Affymetrix), were hybridized to the arrays for 16 hours at 45 degrees-Celsius and 60 rpm.  Arrays were washed and stained according to the standard Antibody Amplification for Eukaryotic Targets protocol (Affymetrix).","V18":"For each GeneChip, 20 micrograms of the labeled product was fragmented in 40 mM Tris-acetate, pH 8.1, 100mM KOAc, 30mM MgOAc, for 35 minutes at 94 degrees-Celsius, to an average size of 35 to 200 bases.  15 micrograms of this fragmented, biotinylated cRNA, along with hybridization controls supplied by the manufacturer (Affymetrix), were hybridized to the arrays for 16 hours at 45 degrees-Celsius and 60 rpm.  Arrays were washed and stained according to the standard Antibody Amplification for Eukaryotic Targets protocol (Affymetrix).","V19":"For each GeneChip, 20 micrograms of the labeled product was fragmented in 40 mM Tris-acetate, pH 8.1, 100mM KOAc, 30mM MgOAc, for 35 minutes at 94 degrees-Celsius, to an average size of 35 to 200 bases.  15 micrograms of this fragmented, biotinylated cRNA, along with hybridization controls supplied by the manufacturer (Affymetrix), were hybridized to the arrays for 16 hours at 45 degrees-Celsius and 60 rpm.  Arrays were washed and stained according to the standard Antibody Amplification for Eukaryotic Targets protocol (Affymetrix).","V20":"For each GeneChip, 20 micrograms of the labeled product was fragmented in 40 mM Tris-acetate, pH 8.1, 100mM KOAc, 30mM MgOAc, for 35 minutes at 94 degrees-Celsius, to an average size of 35 to 200 bases.  15 micrograms of this fragmented, biotinylated cRNA, along with hybridization controls supplied by the manufacturer (Affymetrix), were hybridized to the arrays for 16 hours at 45 degrees-Celsius and 60 rpm.  Arrays were washed and stained according to the standard Antibody Amplification for Eukaryotic Targets protocol (Affymetrix).","V21":"For each GeneChip, 20 micrograms of the labeled product was fragmented in 40 mM Tris-acetate, pH 8.1, 100mM KOAc, 30mM MgOAc, for 35 minutes at 94 degrees-Celsius, to an average size of 35 to 200 bases.  15 micrograms of this fragmented, biotinylated cRNA, along with hybridization controls supplied by the manufacturer (Affymetrix), were hybridized to the arrays for 16 hours at 45 degrees-Celsius and 60 rpm.  Arrays were washed and stained according to the standard Antibody Amplification for Eukaryotic Targets protocol (Affymetrix).","V22":"For each GeneChip, 20 micrograms of the labeled product was fragmented in 40 mM Tris-acetate, pH 8.1, 100mM KOAc, 30mM MgOAc, for 35 minutes at 94 degrees-Celsius, to an average size of 35 to 200 bases.  15 micrograms of this fragmented, biotinylated cRNA, along with hybridization controls supplied by the manufacturer (Affymetrix), were hybridized to the arrays for 16 hours at 45 degrees-Celsius and 60 rpm.  Arrays were washed and stained according to the standard Antibody Amplification for Eukaryotic Targets protocol (Affymetrix).","V23":"For each GeneChip, 20 micrograms of the labeled product was fragmented in 40 mM Tris-acetate, pH 8.1, 100mM KOAc, 30mM MgOAc, for 35 minutes at 94 degrees-Celsius, to an average size of 35 to 200 bases.  15 micrograms of this fragmented, biotinylated cRNA, along with hybridization controls supplied by the manufacturer (Affymetrix), were hybridized to the arrays for 16 hours at 45 degrees-Celsius and 60 rpm.  Arrays were washed and stained according to the standard Antibody Amplification for Eukaryotic Targets protocol (Affymetrix).","V24":"For each GeneChip, 20 micrograms of the labeled product was fragmented in 40 mM Tris-acetate, pH 8.1, 100mM KOAc, 30mM MgOAc, for 35 minutes at 94 degrees-Celsius, to an average size of 35 to 200 bases.  15 micrograms of this fragmented, biotinylated cRNA, along with hybridization controls supplied by the manufacturer (Affymetrix), were hybridized to the arrays for 16 hours at 45 degrees-Celsius and 60 rpm.  Arrays were washed and stained according to the standard Antibody Amplification for Eukaryotic Targets protocol (Affymetrix).","V25":"For each GeneChip, 20 micrograms of the labeled product was fragmented in 40 mM Tris-acetate, pH 8.1, 100mM KOAc, 30mM MgOAc, for 35 minutes at 94 degrees-Celsius, to an average size of 35 to 200 bases.  15 micrograms of this fragmented, biotinylated cRNA, along with hybridization controls supplied by the manufacturer (Affymetrix), were hybridized to the arrays for 16 hours at 45 degrees-Celsius and 60 rpm.  Arrays were washed and stained according to the standard Antibody Amplification for Eukaryotic Targets protocol (Affymetrix).","V26":"For each GeneChip, 20 micrograms of the labeled product was fragmented in 40 mM Tris-acetate, pH 8.1, 100mM KOAc, 30mM MgOAc, for 35 minutes at 94 degrees-Celsius, to an average size of 35 to 200 bases.  15 micrograms of this fragmented, biotinylated cRNA, along with hybridization controls supplied by the manufacturer (Affymetrix), were hybridized to the arrays for 16 hours at 45 degrees-Celsius and 60 rpm.  Arrays were washed and stained according to the standard Antibody Amplification for Eukaryotic Targets protocol (Affymetrix).","V27":"For each GeneChip, 20 micrograms of the labeled product was fragmented in 40 mM Tris-acetate, pH 8.1, 100mM KOAc, 30mM MgOAc, for 35 minutes at 94 degrees-Celsius, to an average size of 35 to 200 bases.  15 micrograms of this fragmented, biotinylated cRNA, along with hybridization controls supplied by the manufacturer (Affymetrix), were hybridized to the arrays for 16 hours at 45 degrees-Celsius and 60 rpm.  Arrays were washed and stained according to the standard Antibody Amplification for Eukaryotic Targets protocol (Affymetrix)."}
{"V1":"!Sample_scan_protocol","V2":"The stained GeneChip arrays were scanned at 488 nm using an Affymetrix Gene Chip Scanner 3000 (Affymetrix, Santa Clara, CA).","V3":"The stained GeneChip arrays were scanned at 488 nm using an Affymetrix Gene Chip Scanner 3000 (Affymetrix, Santa Clara, CA).","V4":"The stained GeneChip arrays were scanned at 488 nm using an Affymetrix Gene Chip Scanner 3000 (Affymetrix, Santa Clara, CA).","V5":"The stained GeneChip arrays were scanned at 488 nm using an Affymetrix Gene Chip Scanner 3000 (Affymetrix, Santa Clara, CA).","V6":"The stained GeneChip arrays were scanned at 488 nm using an Affymetrix Gene Chip Scanner 3000 (Affymetrix, Santa Clara, CA).","V7":"The stained GeneChip arrays were scanned at 488 nm using an Affymetrix Gene Chip Scanner 3000 (Affymetrix, Santa Clara, CA).","V8":"The stained GeneChip arrays were scanned at 488 nm using an Affymetrix Gene Chip Scanner 3000 (Affymetrix, Santa Clara, CA).","V9":"The stained GeneChip arrays were scanned at 488 nm using an Affymetrix Gene Chip Scanner 3000 (Affymetrix, Santa Clara, CA).","V10":"The stained GeneChip arrays were scanned at 488 nm using an Affymetrix Gene Chip Scanner 3000 (Affymetrix, Santa Clara, CA).","V11":"The stained GeneChip arrays were scanned at 488 nm using an Affymetrix Gene Chip Scanner 3000 (Affymetrix, Santa Clara, CA).","V12":"The stained GeneChip arrays were scanned at 488 nm using an Affymetrix Gene Chip Scanner 3000 (Affymetrix, Santa Clara, CA).","V13":"The stained GeneChip arrays were scanned at 488 nm using an Affymetrix Gene Chip Scanner 3000 (Affymetrix, Santa Clara, CA).","V14":"The stained GeneChip arrays were scanned at 488 nm using an Affymetrix Gene Chip Scanner 3000 (Affymetrix, Santa Clara, CA).","V15":"The stained GeneChip arrays were scanned at 488 nm using an Affymetrix Gene Chip Scanner 3000 (Affymetrix, Santa Clara, CA).","V16":"The stained GeneChip arrays were scanned at 488 nm using an Affymetrix Gene Chip Scanner 3000 (Affymetrix, Santa Clara, CA).","V17":"The stained GeneChip arrays were scanned at 488 nm using an Affymetrix Gene Chip Scanner 3000 (Affymetrix, Santa Clara, CA).","V18":"The stained GeneChip arrays were scanned at 488 nm using an Affymetrix Gene Chip Scanner 3000 (Affymetrix, Santa Clara, CA).","V19":"The stained GeneChip arrays were scanned at 488 nm using an Affymetrix Gene Chip Scanner 3000 (Affymetrix, Santa Clara, CA).","V20":"The stained GeneChip arrays were scanned at 488 nm using an Affymetrix Gene Chip Scanner 3000 (Affymetrix, Santa Clara, CA).","V21":"The stained GeneChip arrays were scanned at 488 nm using an Affymetrix Gene Chip Scanner 3000 (Affymetrix, Santa Clara, CA).","V22":"The stained GeneChip arrays were scanned at 488 nm using an Affymetrix Gene Chip Scanner 3000 (Affymetrix, Santa Clara, CA).","V23":"The stained GeneChip arrays were scanned at 488 nm using an Affymetrix Gene Chip Scanner 3000 (Affymetrix, Santa Clara, CA).","V24":"The stained GeneChip arrays were scanned at 488 nm using an Affymetrix Gene Chip Scanner 3000 (Affymetrix, Santa Clara, CA).","V25":"The stained GeneChip arrays were scanned at 488 nm using an Affymetrix Gene Chip Scanner 3000 (Affymetrix, Santa Clara, CA).","V26":"The stained GeneChip arrays were scanned at 488 nm using an Affymetrix Gene Chip Scanner 3000 (Affymetrix, Santa Clara, CA).","V27":"The stained GeneChip arrays were scanned at 488 nm using an Affymetrix Gene Chip Scanner 3000 (Affymetrix, Santa Clara, CA)."}
{"V1":"!Sample_description","V2":"flow-cytometry: B220+, CD5–, CD19+, CD25–, CD69–, B7-1–, B7-2–, IgD+, sIgM+; clinical-signs: none","V3":"flow-cytometry: B220+, CD5–, CD19+, CD25+, CD69+, B7-1+, B7-2+, IgDlo, sIgMlo; clinical-signs: none","V4":"flow-cytometry: B220+, CD5–, CD19+, CD25–, CD69–, B7-1–, B7-2–, IgD+, sIgM+; clinical-signs: none","V5":"flow-cytometry: B220+, CD5–, CD19+, CD25–, CD69–, B7-1–, B7-2–, IgD+, sIgM+; clinical-signs: none","V6":"flow-cytometry: ND; clinical-signs: neck tumor","V7":"flow-cytometry: ND; clinical-signs: failure to nest","V8":"flow-cytometry: ND; clinical-signs: failure to nest","V9":"flow-cytometry: B220+, CD5+, CD9+, CD19+, CD23lo, CD25–, CD69–, sIgM+, B7-1+, B7-2+; clinical-signs: end-stage","V10":"flow-cytometry: B220+, CD5+, CD9+, CD19+, CD23lo, CD25–, CD69–, sIgM+, B7-1+, B7-2+; clinical-signs: end-stage","V11":"flow-cytometry: ND; clinical-signs: leg tumor","V12":"flow-cytometry: ND; clinical-signs: haunch tumor","V13":"flow-cytometry: B220+, CD5+, CD11b+; clinical-signs: paralysis","V14":"flow-cytometry: ND; clinical-signs: failure to nest","V15":"flow-cytometry: ND; clinical-signs: failure to nest","V16":"flow-cytometry: ND; clinical-signs: failure to nest","V17":"flow-cytometry: ND; clinical-signs: failure to nest","V18":"flow-cytometry: ND; clinical-signs: failure to nest","V19":"flow-cytometry: B220+, CD5–, CD19+, CD25–, CD69–, B7-1–, B7-2–, IgD+, sIgM+; clinical-signs: conjunctivitis","V20":"flow-cytometry: B220+, CD5+, CD9+, CD19+, CD23lo, CD25–, CD69–, sIgM+, B7-1+, B7-2+; clinical-signs: end-stage","V21":"flow-cytometry: B220+, CD5+, CD9+, CD19+, CD23lo, CD25–, CD69–, sIgM+, B7-1+, B7-2+; clinical-signs: end-stage","V22":"flow-cytometry: B220+, CD5+, CD9+, CD19+, CD23lo, CD25–, CD69–, sIgM+, B7-1+, B7-2+; clinical-signs: end-stage","V23":"flow-cytometry: B220+, CD5+, CD9+, CD19+, CD23lo, CD25–, CD69–, sIgM+, B7-1+, B7-2+; clinical-signs: end-stage","V24":"flow-cytometry: B220+, CD5+, CD9+, CD19+, CD23lo, CD25–, CD69–, sIgM+, B7-1+, B7-2+; clinical-signs: end-stage","V25":"flow-cytometry: B220+, CD5–, CD19+, CD25–, CD69–, B7-1–, B7-2–, IgD+, sIgM+; clinical-signs: none","V26":"flow-cytometry: B220+, CD5–, CD19+, CD25+, CD69+, B7-1+, B7-2+, IgDlo, sIgMlo; clinical-signs: none","V27":"flow-cytometry: B220+, CD5–, CD19+, CD25+, CD69+, B7-1+, B7-2+, IgDlo, sIgMlo; clinical-signs: none"}
{"V1":"!Sample_data_processing","V2":"MAS5.0, target intensity = 500","V3":"MAS5.0, target intensity = 500","V4":"MAS5.0, target intensity = 500","V5":"MAS5.0, target intensity = 500","V6":"MAS5.0, target intensity = 500","V7":"MAS5.0, target intensity = 500","V8":"MAS5.0, target intensity = 500","V9":"MAS5.0, target intensity = 500","V10":"MAS5.0, target intensity = 500","V11":"MAS5.0, target intensity = 500","V12":"MAS5.0, target intensity = 500","V13":"MAS5.0, target intensity = 500","V14":"MAS5.0, target intensity = 500","V15":"MAS5.0, target intensity = 500","V16":"MAS5.0, target intensity = 500","V17":"MAS5.0, target intensity = 500","V18":"MAS5.0, target intensity = 500","V19":"MAS5.0, target intensity = 500","V20":"MAS5.0, target intensity = 500","V21":"MAS5.0, target intensity = 500","V22":"MAS5.0, target intensity = 500","V23":"MAS5.0, target intensity = 500","V24":"MAS5.0, target intensity = 500","V25":"MAS5.0, target intensity = 500","V26":"MAS5.0, target intensity = 500","V27":"MAS5.0, target intensity = 500"}
{"V1":"!Sample_platform_id","V2":"GPL8321","V3":"GPL8321","V4":"GPL8321","V5":"GPL8321","V6":"GPL8321","V7":"GPL8321","V8":"GPL8321","V9":"GPL8321","V10":"GPL8321","V11":"GPL8321","V12":"GPL8321","V13":"GPL8321","V14":"GPL8321","V15":"GPL8321","V16":"GPL8321","V17":"GPL8321","V18":"GPL8321","V19":"GPL8321","V20":"GPL8321","V21":"GPL8321","V22":"GPL8321","V23":"GPL8321","V24":"GPL8321","V25":"GPL8321","V26":"GPL8321","V27":"GPL8321"}
{"V1":"!Sample_contact_name","V2":"Marc,E.,Lenburg","V3":"Marc,E.,Lenburg","V4":"Marc,E.,Lenburg","V5":"Marc,E.,Lenburg","V6":"Marc,E.,Lenburg","V7":"Marc,E.,Lenburg","V8":"Marc,E.,Lenburg","V9":"Marc,E.,Lenburg","V10":"Marc,E.,Lenburg","V11":"Marc,E.,Lenburg","V12":"Marc,E.,Lenburg","V13":"Marc,E.,Lenburg","V14":"Marc,E.,Lenburg","V15":"Marc,E.,Lenburg","V16":"Marc,E.,Lenburg","V17":"Marc,E.,Lenburg","V18":"Marc,E.,Lenburg","V19":"Marc,E.,Lenburg","V20":"Marc,E.,Lenburg","V21":"Marc,E.,Lenburg","V22":"Marc,E.,Lenburg","V23":"Marc,E.,Lenburg","V24":"Marc,E.,Lenburg","V25":"Marc,E.,Lenburg","V26":"Marc,E.,Lenburg","V27":"Marc,E.,Lenburg"}
{"V1":"!Sample_contact_email","V2":"mlenburg@bu.edu","V3":"mlenburg@bu.edu","V4":"mlenburg@bu.edu","V5":"mlenburg@bu.edu","V6":"mlenburg@bu.edu","V7":"mlenburg@bu.edu","V8":"mlenburg@bu.edu","V9":"mlenburg@bu.edu","V10":"mlenburg@bu.edu","V11":"mlenburg@bu.edu","V12":"mlenburg@bu.edu","V13":"mlenburg@bu.edu","V14":"mlenburg@bu.edu","V15":"mlenburg@bu.edu","V16":"mlenburg@bu.edu","V17":"mlenburg@bu.edu","V18":"mlenburg@bu.edu","V19":"mlenburg@bu.edu","V20":"mlenburg@bu.edu","V21":"mlenburg@bu.edu","V22":"mlenburg@bu.edu","V23":"mlenburg@bu.edu","V24":"mlenburg@bu.edu","V25":"mlenburg@bu.edu","V26":"mlenburg@bu.edu","V27":"mlenburg@bu.edu"}
{"V1":"!Sample_contact_phone","V2":"617-414-1375","V3":"617-414-1375","V4":"617-414-1375","V5":"617-414-1375","V6":"617-414-1375","V7":"617-414-1375","V8":"617-414-1375","V9":"617-414-1375","V10":"617-414-1375","V11":"617-414-1375","V12":"617-414-1375","V13":"617-414-1375","V14":"617-414-1375","V15":"617-414-1375","V16":"617-414-1375","V17":"617-414-1375","V18":"617-414-1375","V19":"617-414-1375","V20":"617-414-1375","V21":"617-414-1375","V22":"617-414-1375","V23":"617-414-1375","V24":"617-414-1375","V25":"617-414-1375","V26":"617-414-1375","V27":"617-414-1375"}
{"V1":"!Sample_contact_fax","V2":"617-414-1646","V3":"617-414-1646","V4":"617-414-1646","V5":"617-414-1646","V6":"617-414-1646","V7":"617-414-1646","V8":"617-414-1646","V9":"617-414-1646","V10":"617-414-1646","V11":"617-414-1646","V12":"617-414-1646","V13":"617-414-1646","V14":"617-414-1646","V15":"617-414-1646","V16":"617-414-1646","V17":"617-414-1646","V18":"617-414-1646","V19":"617-414-1646","V20":"617-414-1646","V21":"617-414-1646","V22":"617-414-1646","V23":"617-414-1646","V24":"617-414-1646","V25":"617-414-1646","V26":"617-414-1646","V27":"617-414-1646"}
{"V1":"!Sample_contact_department","V2":"Genetics and Genomics","V3":"Genetics and Genomics","V4":"Genetics and Genomics","V5":"Genetics and Genomics","V6":"Genetics and Genomics","V7":"Genetics and Genomics","V8":"Genetics and Genomics","V9":"Genetics and Genomics","V10":"Genetics and Genomics","V11":"Genetics and Genomics","V12":"Genetics and Genomics","V13":"Genetics and Genomics","V14":"Genetics and Genomics","V15":"Genetics and Genomics","V16":"Genetics and Genomics","V17":"Genetics and Genomics","V18":"Genetics and Genomics","V19":"Genetics and Genomics","V20":"Genetics and Genomics","V21":"Genetics and Genomics","V22":"Genetics and Genomics","V23":"Genetics and Genomics","V24":"Genetics and Genomics","V25":"Genetics and Genomics","V26":"Genetics and Genomics","V27":"Genetics and Genomics"}
{"V1":"!Sample_contact_institute","V2":"Boston University School of Medicine","V3":"Boston University School of Medicine","V4":"Boston University School of Medicine","V5":"Boston University School of Medicine","V6":"Boston University School of Medicine","V7":"Boston University School of Medicine","V8":"Boston University School of Medicine","V9":"Boston University School of Medicine","V10":"Boston University School of Medicine","V11":"Boston University School of Medicine","V12":"Boston University School of Medicine","V13":"Boston University School of Medicine","V14":"Boston University School of Medicine","V15":"Boston University School of Medicine","V16":"Boston University School of Medicine","V17":"Boston University School of Medicine","V18":"Boston University School of Medicine","V19":"Boston University School of Medicine","V20":"Boston University School of Medicine","V21":"Boston University School of Medicine","V22":"Boston University School of Medicine","V23":"Boston University School of Medicine","V24":"Boston University School of Medicine","V25":"Boston University School of Medicine","V26":"Boston University School of Medicine","V27":"Boston University School of Medicine"}
{"V1":"!Sample_contact_address","V2":"715 Albany Street, E613B","V3":"715 Albany Street, E613B","V4":"715 Albany Street, E613B","V5":"715 Albany Street, E613B","V6":"715 Albany Street, E613B","V7":"715 Albany Street, E613B","V8":"715 Albany Street, E613B","V9":"715 Albany Street, E613B","V10":"715 Albany Street, E613B","V11":"715 Albany Street, E613B","V12":"715 Albany Street, E613B","V13":"715 Albany Street, E613B","V14":"715 Albany Street, E613B","V15":"715 Albany Street, E613B","V16":"715 Albany Street, E613B","V17":"715 Albany Street, E613B","V18":"715 Albany Street, E613B","V19":"715 Albany Street, E613B","V20":"715 Albany Street, E613B","V21":"715 Albany Street, E613B","V22":"715 Albany Street, E613B","V23":"715 Albany Street, E613B","V24":"715 Albany Street, E613B","V25":"715 Albany Street, E613B","V26":"715 Albany Street, E613B","V27":"715 Albany Street, E613B"}
{"V1":"!Sample_contact_city","V2":"Boston","V3":"Boston","V4":"Boston","V5":"Boston","V6":"Boston","V7":"Boston","V8":"Boston","V9":"Boston","V10":"Boston","V11":"Boston","V12":"Boston","V13":"Boston","V14":"Boston","V15":"Boston","V16":"Boston","V17":"Boston","V18":"Boston","V19":"Boston","V20":"Boston","V21":"Boston","V22":"Boston","V23":"Boston","V24":"Boston","V25":"Boston","V26":"Boston","V27":"Boston"}
{"V1":"!Sample_contact_state","V2":"MA","V3":"MA","V4":"MA","V5":"MA","V6":"MA","V7":"MA","V8":"MA","V9":"MA","V10":"MA","V11":"MA","V12":"MA","V13":"MA","V14":"MA","V15":"MA","V16":"MA","V17":"MA","V18":"MA","V19":"MA","V20":"MA","V21":"MA","V22":"MA","V23":"MA","V24":"MA","V25":"MA","V26":"MA","V27":"MA"}
{"V1":"!Sample_contact_zip/postal_code","V2":"2130","V3":"2130","V4":"2130","V5":"2130","V6":"2130","V7":"2130","V8":"2130","V9":"2130","V10":"2130","V11":"2130","V12":"2130","V13":"2130","V14":"2130","V15":"2130","V16":"2130","V17":"2130","V18":"2130","V19":"2130","V20":"2130","V21":"2130","V22":"2130","V23":"2130","V24":"2130","V25":"2130","V26":"2130","V27":"2130"}
{"V1":"!Sample_contact_country","V2":"USA","V3":"USA","V4":"USA","V5":"USA","V6":"USA","V7":"USA","V8":"USA","V9":"USA","V10":"USA","V11":"USA","V12":"USA","V13":"USA","V14":"USA","V15":"USA","V16":"USA","V17":"USA","V18":"USA","V19":"USA","V20":"USA","V21":"USA","V22":"USA","V23":"USA","V24":"USA","V25":"USA","V26":"USA","V27":"USA"}
{"V1":"!Sample_contact_web_link","V2":"http://gg.bu.edu","V3":"http://gg.bu.edu","V4":"http://gg.bu.edu","V5":"http://gg.bu.edu","V6":"http://gg.bu.edu","V7":"http://gg.bu.edu","V8":"http://gg.bu.edu","V9":"http://gg.bu.edu","V10":"http://gg.bu.edu","V11":"http://gg.bu.edu","V12":"http://gg.bu.edu","V13":"http://gg.bu.edu","V14":"http://gg.bu.edu","V15":"http://gg.bu.edu","V16":"http://gg.bu.edu","V17":"http://gg.bu.edu","V18":"http://gg.bu.edu","V19":"http://gg.bu.edu","V20":"http://gg.bu.edu","V21":"http://gg.bu.edu","V22":"http://gg.bu.edu","V23":"http://gg.bu.edu","V24":"http://gg.bu.edu","V25":"http://gg.bu.edu","V26":"http://gg.bu.edu","V27":"http://gg.bu.edu"}
{"V1":"!Sample_supplementary_file","V2":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM142nnn/GSM142398/suppl/GSM142398.CEL.gz","V3":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM142nnn/GSM142399/suppl/GSM142399.CEL.gz","V4":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM142nnn/GSM142400/suppl/GSM142400.CEL.gz","V5":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM142nnn/GSM142401/suppl/GSM142401.CEL.gz","V6":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM142nnn/GSM142402/suppl/GSM142402.CEL.gz","V7":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM142nnn/GSM142403/suppl/GSM142403.CEL.gz","V8":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM142nnn/GSM142404/suppl/GSM142404.CEL.gz","V9":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM142nnn/GSM142405/suppl/GSM142405.CEL.gz","V10":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM142nnn/GSM142406/suppl/GSM142406.CEL.gz","V11":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM142nnn/GSM142407/suppl/GSM142407.CEL.gz","V12":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM142nnn/GSM142408/suppl/GSM142408.CEL.gz","V13":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM142nnn/GSM142409/suppl/GSM142409.CEL.gz","V14":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM142nnn/GSM142410/suppl/GSM142410.CEL.gz","V15":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM142nnn/GSM142411/suppl/GSM142411.CEL.gz","V16":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM142nnn/GSM142412/suppl/GSM142412.CEL.gz","V17":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM142nnn/GSM142413/suppl/GSM142413.CEL.gz","V18":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM142nnn/GSM142414/suppl/GSM142414.CEL.gz","V19":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM142nnn/GSM142415/suppl/GSM142415.CEL.gz","V20":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM142nnn/GSM142416/suppl/GSM142416.CEL.gz","V21":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM142nnn/GSM142417/suppl/GSM142417.CEL.gz","V22":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM142nnn/GSM142418/suppl/GSM142418.CEL.gz","V23":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM142nnn/GSM142419/suppl/GSM142419.CEL.gz","V24":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM142nnn/GSM142420/suppl/GSM142420.CEL.gz","V25":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM142nnn/GSM142421/suppl/GSM142421.CEL.gz","V26":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM142nnn/GSM142422/suppl/GSM142422.CEL.gz","V27":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM142nnn/GSM142423/suppl/GSM142423.CEL.gz"}
{"V1":"!Sample_data_row_count","V2":"22690","V3":"22690","V4":"22690","V5":"22690","V6":"22690","V7":"22690","V8":"22690","V9":"22690","V10":"22690","V11":"22690","V12":"22690","V13":"22690","V14":"22690","V15":"22690","V16":"22690","V17":"22690","V18":"22690","V19":"22690","V20":"22690","V21":"22690","V22":"22690","V23":"22690","V24":"22690","V25":"22690","V26":"22690","V27":"22690"}